SCHEMBL7523490

SCHEMBL7523490

C[Si](C)(CI)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 8/20 0.42
NR1H3 Q13133 8/20 0.42
KIF11 P52732 4/20 0.40
TAAR1 Q96RJ0 1/20 0.38
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
IDO1 P14902 1/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
ORAI1 Q96D31 1/20 0.35
ORAI2 Q96SN7 1/20 0.35
ORAI3 Q9BRQ5 1/20 0.35
TRPV6 Q9H1D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9223317 0.82 NR1H2 (0.53) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL4731716 0.80 TSHR (0.42) TAAR1ALDH1A1TSHRIDO1CES2
SCHEMBL8983879 0.78 PTPN1 (0.42) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL7523329 0.78 NR1H2 (0.42) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL12773794 0.74 NR1H2 (0.60) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL1052798 0.74 KIF11 (0.48) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL9226183 0.74 NR1H2 (0.50) NR1H2NR1H3KIF11TAAR1ALDH1A1
SCHEMBL4734052 0.73 LMNA (0.38) TAAR1ALDH1A1IDO1
SCHEMBL18691999 0.70 NR1H2 (0.45) NR1H2NR1H3KIF11ALDH1A1TSHR
SCHEMBL9662228 0.70 NR1H2 (0.47) NR1H2NR1H3KIF11TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900225-B1 ALKYL-4-SILYL-PHENOLS AND ESTERS THEREOF AS ANTIATHEROSCLEROTIC AGENTS AVENTIS PHARMA INC (US) 2002-01-30 EP disclosed
US-5608095-A Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents HOECHST MARION ROUSSEL, INC. (US) 1997-03-04 US disclosed